CYTK Cytokinetics, Incorporated - Common Stock
$76,48
Harga · Agu 18, 2026
Fundamental per Agu 6, 2026
Rentang 52M
$35–$88
78% of range
Peringkat Analis
BUY
28 analysts
Target Harga
$110
+44% upside
P/E (TTM)
-11.7
ROE
152.7%
Margin Laba Bersih
-891.6%
Tentang Cytokinetics, Incorporated - Common Stock Tinjauan perusahaan dari Wikipedia
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
Baca selengkapnya
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
History
Cytokinetics was founded in 1997 by James Spudich, Ronald Vale, James Sabry and Lawrence S.B. Goldstein, four scientists at Stanford, UCSD, and UCSF. Operations began in 1998.
Initially, Cytokinetics focused on the possible pharmacological targets and areas of application of drugs based on cytoskeletal proteins. Eventually, the company narrowed its focus to the mechanics of muscle biology. Cytokinetics develops muscle activators and muscle inhibitors to improve muscle function in patients with cardiovascular and neuromuscular diseases.
In 2004 the company completed its initial public offering (IPO).
In January 2007, Cytokinetics named Robert I. Blum as president and CEO. Prior to this, Blum has been involved in the company since its founding, with roles in business development, corporate development and R&D.
In 2013, Cytokinetics finalized a licensing and discovery deal with Astellas to research treatment for muscle weakness and fatigue.
In July 2020, Ji Xing Pharmaceuticals signed a financing deal with Cytokinetics, which included the rights to commercialize the drug designed to treat hypertrophic cardiomyopathies, aficamten, in China and certain neighboring regions.
Products
Omecamtiv mecarbil is a cardiac muscle activator for the potential treatment of heart failure. In May 2020, omecamtiv mecarbil was granted fast track designation by the FDA for the treatment of chronic HF with reduced ejection fraction. Amgen purchased an option on omecamtiv mecarbil in 2006, and the two companies extended their partnership several times. In June 2013, Cytokinetics and Amgen expanded their licensing deal for omecamtiv mecarbil to include Japan. In November 2020 Amgen elected to terminate the collaboration, effective May 20, 2021, and Cytokinetics regained worldwide rights to develop and commercialize omecamtiv mecarbil.
Reldesemtiv (previously known as CK-2127107) is a next-generation fast skeletal muscle troponin activator (FSTA) that has undergone clinical trials for ALS.
Aficamten (previously known as CK-3773274) is an oral, small-molecule myosin inhibitor, to treat hypertrophic cardiomyopathy (HCM).
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
CYTK Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$76.48
Kapitalisasi Pasar
$9.40B
P/E (TTM)
-11.7
EPS (TTM)
$-6.54
Pendapatan (TTM)
$88M
Imbal Hasil Dividen
—
ROE
152.7%
D/E Utang/Ekuitas
-0.4
Rentang 52M
$35 – $88
CYTK Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
$88M
2016-12-31
→
2025-12-31
EPS
$-6.54
2016-12-31
→
2025-12-31
Arus Kas Bebas
$-535M
2016-12-31
→
2025-12-31
Margin
-891.6%
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
CYTK
Median Rekan
P/E (TTM)
-11.7
28.5
P/S (TTM)
106.8
20.1
P/B
-14.3
12.9
EV / EBITDA
-15.9
—
Price / FCF (Harga / FCF)
-17.6
—
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
CYTK
Median Rekan
Operating Margin (Margin Operasi)
-695.4%
—
Net Profit Margin (Margin Laba Bersih)
-891.6%
-48.4%
ROA
-55.5%
-28.4%
ROE
152.7%
-49.2%
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
CYTK
Median Rekan
Debt / Equity (Utang / Ekuitas)
-0.4
—
Current Ratio (Rasio Lancar)
4.5
5.0
Quick Ratio (Rasio Cepat)
0.7
—
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
CYTK
Median Rekan
Revenue YoY (Pendapatan YoY)
376.6%
—
Revenue CAGR 3Y (CAGR Pendapatan 3T)
-2.4%
—
Revenue CAGR 5Y (CAGR Pendapatan 5T)
9.5%
—
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
CYTK
Median Rekan
CYTK Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
28 analis
- Beli Kuat 6 21,4%
- Beli 19 67,9%
- Tahan 3 10,7%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
20 analis · 2026-08-18
Median
$107.50
← Di bawah semua target
$76.48
Rendah
$85.00
Tinggi
$146.00
Target median
$107.50
+40,6%
Target rata-rata
$109.90
+43,7%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-0.08%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $-1.50 | $-1.67 | 0.17% |
| 31 Maret 2026 | $-1.67 | $-1.69 | 0.02% |
| 31 Des. 2025 | $-1.50 | $-1.49 | -0.01% |
| 30 Sep. 2025 | $-2.55 | $-1.61 | -0.94% |
| 30 Juni 2025 | $-1.12 | $-1.41 | 0.28% |
| 31 Maret 2025 | $-1.39 | $-1.41 | 0.02% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| CYTK | $7.81B | -9.7 | 376.6% | -891.6% | 152.7% | — |
| ARWR | $4.68B | -3449.0 | 23258.2% | -0.20% | -0.50% | — |
| MDGL | $13.30B | -45.3 | 432.1% | -30.1% | -44.4% | — |
| HALO | $7.93B | 26.3 | 37.5% | 22.7% | 166.1% | — |
| PRAX | $7.43B | -21.9 | 249.5% | — | -47.3% | — |
| APGE | $5.16B | -17.9 | — | — | — | — |
| PTGX | $5.47B | -42.6 | -89.4% | -282.8% | -20.3% | — |
| KRYS | $7.20B | 36.0 | 33.9% | 52.6% | 18.1% | — |
| KYMR | $6.33B | -21.1 | -16.7% | -794.0% | -24.4% | — |
| SMMT | $13.56B | -12.1 | — | — | -235.1% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 16
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $88M | $18M | $8M | $95M | $70M | $56M | $27M | $32M | $13M | $106M | $29M | $47M | |
| R&D Expense | $416M | $339M | $330M | $241M | $160M | $97M | $86M | $89M | $90M | $60M | $46M | $44M | |
| SG&A Expense | $284M | $215M | $174M | $178M | $97M | $53M | $40M | $31M | $36M | $28M | $20M | $17M | |
| Operating Expenses | $700M | $555M | $504M | $419M | $257M | $150M | $126M | $120M | $127M | $88M | $66M | $62M | |
| Operating Income | $-612M | $-536M | $-496M | $-324M | $-186M | $-94M | $-99M | $-89M | $-113M | $19M | $-37M | $-15M | |
| Interest Expense | $46M | $38M | $28M | $19M | $16M | $16M | $7M | $4M | $3M | $3M | $268.0K | $0 | |
| Interest Income | · | · | · | $11M | $1M | $5M | $4M | $4M | · | $449.0K | $156.0K | $101.0K | |
| Other Non-op | $48M | $52M | $28M | $11M | $331.0K | $5M | $5M | $4M | $3M | $464.0K | $174.0K | $108.0K | |
| Pretax Income | · | · | · | · | · | · | · | $-106M | $-128M | $16M | $-38M | $-15M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-785M | $-590M | $-526M | $-389M | $-215M | $-127M | $-122M | $-106M | $-128M | $16M | $-38M | $-15M | |
| EPS (Basic) | $-6.54 | $-5.26 | $-5.45 | $-4.33 | $-2.80 | $-1.97 | · | · | $-2.59 | $0.41 | $-0.97 | $-0.41 | |
| EPS (Diluted) | $-6.54 | $-5.26 | $-5.45 | $-4.33 | $-2.80 | $-1.97 | · | · | $-2.59 | $0.39 | $-0.97 | $-0.41 | |
| Shares (Basic) | 120,103 | 111,979 | 96,524 | 89,825 | 76,886 | 64,524 | · | · | 49,404,000 | 39,943,000 | 38,814,000 | 35,709,000 | |
| Shares (Diluted) | 120,103 | 111,979 | 96,524 | 89,825 | 76,886 | 64,524 | · | · | 49,404,000 | 42,561,000 | 38,814,000 | 35,709,000 | |
| EBITDA | $-602M | $-527M | $-484M | $-318M | $-184M | $-92M | $-98M | $-88M | $-111M | $19M | $-37M | $-14M |
Neraca 26
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $123M | $95M | $113M | $66M | $113M | $83M | $36M | $42M | $125M | $67M | $65M | $20M | |
| Receivables | $18M | $17M | $1M | $147.0K | $52M | $4M | $5M | $2M | $1M | $24.0K | · | · | |
| Inventory | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $17M | $15M | $12M | $12M | $12M | $6M | $3M | $2M | $4M | $2M | $2M | $1M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Assets | $917M | $1.11B | $628M | $795M | $536M | $474M | $234M | $208M | $274M | $159M | $113M | $131M | |
| PP&E (Net) | $79M | $66M | $69M | $80M | $73M | $13M | $5M | $3M | $4M | $4M | $2M | $2M | |
| PP&E (Gross) | $126M | $103M | $97M | $98M | $89M | $38M | $29M | $27M | $26M | $25M | $23M | $22M | |
| Accum. Depreciation | $47M | $37M | $28M | $17M | $16M | $25M | $24M | $24M | $23M | $21M | $21M | $20M | |
| Other Non-current Assets | $17M | $8M | $8M | $10M | $7M | $6M | · | $300.0K | $429.0K | $200.0K | $200.0K | $200.0K | |
| Total Assets | $1.42B | $1.40B | $824M | $1.01B | $841M | $534M | $290M | $211M | $295M | $170M | $115M | $133M | |
| Accounts Payable | $22M | $20M | $22M | $26M | $21M | $8M | $8M | $4M | $5M | $4M | $2M | $1M | |
| Accrued Liabilities | $83M | $55M | $43M | $44M | $34M | $19M | $12M | $16M | $17M | $18M | $8M | $5M | |
| Current Liabilities | $202M | $180M | $103M | $85M | $72M | $31M | $26M | $22M | $32M | $33M | $32M | $24M | |
| Capital Leases | $108M | $113M | $120M | $127M | $112M | $440.0K | $2M | $771.0K | · | · | · | · | |
| Other Non-current Liabilities | · | $0 | $186.0K | $1M | $4M | $0 | · | $771.0K | $1M | $142.0K | · | · | |
| Total Liabilities | $2.08B | $1.54B | $1.21B | $1.12B | $597M | $420M | $301M | $185M | $185M | $76M | $47M | $41M | |
| Long-term Debt | $288M | $620M | $639M | $650M | · | $46M | $45M | $42M | $32M | $30M | $15M | · | |
| Total Debt | $288M | $105M | $68M | $64M | $47M | $46M | $45M | $42M | $32M | $30M | $15M | · | |
| Common Stock | $123.0K | $118.0K | $102.0K | $94.0K | $84.0K | $70.0K | $59.0K | $55.0K | $54.0K | $41.0K | $40.0K | $39.0K | |
| Paid-in Capital | · | · | · | · | $1.45B | · | · | · | · | · | · | $589M | |
| Retained Earnings | $-3.49B | $-2.70B | $-2.11B | $-1.59B | $-1.21B | $-992M | $-865M | $-743M | $-646M | $-518M | $-535M | $-497M | |
| AOCI | $630.0K | $2M | $-10.0K | $-4M | $-869.0K | $149.0K | $679.0K | $500.0K | $343.0K | $137.0K | $149.0K | $-4.0K | |
| Stockholders' Equity | $-660M | $-135M | $-386M | $-108M | $244M | $113M | $-11M | $26M | $110M | $94M | $69M | $92M | |
| Liabilities + Equity | $1.42B | $1.40B | $824M | $1.01B | $841M | $534M | $290M | $211M | $295M | $170M | $115M | $133M | |
| Shares Outstanding | 122,943,172 | 118,209,139 | 101,637,922 | 94,833,975 | 84,799,542 | 71,015,183 | 59,172,124 | 54,717,906 | 53,960,832 | 40,646,595 | 39,581,692 | 38,659,738 |
Arus Kas 16
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $10M | $10M | $12M | $6M | $2M | $2M | $1M | $1M | $2M | $741.0K | $589.0K | $490.0K | |
| Stock-based Comp | $112M | $98M | $72M | $48M | $27M | $18M | $11M | $10M | $9M | $7M | $5M | $3M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Other Non-cash | $153M | $86M | $28M | $36M | $44M | $117M | $19M | $-6M | $15M | $13M | $37M | $-34M | |
| Operating Cash Flow | $-510M | $-396M | $-414M | $-300M | $-143M | $9M | $-91M | $-101M | $-102M | $37M | $5M | $-45M | |
| CapEx | $25M | $4M | $1M | $11M | $49M | $11M | $3M | $889.0K | $3M | $2M | $562.0K | $1M | |
| Investing Cash Flow | $17M | $-553M | $239M | $-262M | $-148M | $-197M | $-75M | $5M | $-66M | · | · | · | |
| Net Debt Issued | $-11M | $-9M | · | $-48M | · | · | · | · | · | · | · | · | |
| Stock Issued | · | · | $164M | · | $0 | $0 | $36M | $0 | $112M | $0 | $9M | $49M | |
| Net Stock Activity | · | · | $164M | · | $0 | $0 | $36M | $0 | $112M | $0 | $9M | $49M | |
| Financing Cash Flow | $524M | $931M | $221M | $516M | $320M | $234M | $160M | $13M | $226M | · | · | · | |
| Net Change in Cash | $30M | $-18M | $46M | $-45M | $30M | $47M | $-6M | $-83M | $58M | $2M | $45M | $57.0K | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | · | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Free Cash Flow | $-535M | $-400M | $-416M | $-311M | $-191M | $-2M | $-94M | $-102M | $-105M | $35M | $4M | $-46M | |
| Levered FCF | · | · | · | · | · | · | · | $-106M | $-108M | $33M | · | $-46M |
Profitabilitas 7
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -695.4% | -2902.7% | -6589.7% | -342.8% | -264.5% | -168.3% | -368.0% | -282.3% | -848.3% | 17.6% | -130.5% | -31.4% | |
| Net Margin | -891.6% | -3191.1% | -6988.6% | -411.2% | -305.7% | -228.0% | -452.9% | -337.4% | -955.9% | 15.5% | -130.9% | -31.2% | |
| Pretax Margin | · | · | · | · | · | · | · | -337.4% | -955.9% | 15.5% | -130.9% | -31.2% | |
| EBITDA Margin | -683.9% | -2851.1% | -6431.8% | -336.6% | -261.3% | -165.0% | -363.2% | -278.3% | -833.9% | 18.3% | -128.5% | -30.4% | |
| ROA | -55.5% | -53.0% | -57.2% | -41.9% | -31.3% | -30.9% | -48.6% | -42.0% | -55.0% | 11.5% | -30.2% | -13.6% | |
| ROE | 152.7% | 789.8% | 127.6% | 628.0% | -87.4% | -96.8% | 790.0% | -272.5% | -125.2% | 20.2% | -46.7% | -20.0% | |
| ROIC | · | · | · | · | · | · | · | -130.1% | -80.1% | 15.0% | -44.9% | -16.0% |
Likuiditas & Solvabilitas 5
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 6.2 | 6.1 | 9.4 | 7.5 | 15.2 | 9.0 | 9.4 | 8.5 | 4.8 | 3.6 | 5.5 | |
| Quick Ratio | 0.7 | 0.6 | 1.1 | 0.8 | 2.3 | 2.8 | 1.6 | 2.0 | 3.9 | 2.0 | 2.1 | 0.8 | |
| Debt / Equity | -0.4 | -0.8 | -0.2 | -0.6 | 0.2 | 0.4 | -4.1 | 1.6 | 0.3 | 0.3 | 0.2 | · | |
| LT Debt / Equity | -0.4 | -0.7 | -0.2 | -0.6 | 0.2 | 0.4 | -4.1 | 1.5 | 0.3 | 0.3 | 0.2 | · | |
| Interest Coverage | -13.4 | -14.2 | -17.5 | -16.7 | -11.3 | -5.9 | -14.9 | -23.4 | -37.6 | 6.9 | · | · |
Efisiensi 2
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.7 | 0.2 | 0.4 | |
| Receivables Turnover | 5.1 | 2.1 | 10.5 | 3.6 | 2.5 | 11.7 | 7.3 | 18.8 | 23.5 | · | · | · |
Tingkat Pertumbuhan 3
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 376.6% | 145.3% | -92.0% | 34.3% | 26.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -2.4% | -36.0% | -48.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM) 14
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $88M | $18M | $8M | $95M | $70M | $56M | $27M | $32M | $13M | $106M | $29M | $47M | |
| Net Income TTM | $-785M | $-590M | $-526M | $-389M | $-215M | $-127M | $-122M | $-106M | $-128M | $16M | $-38M | $-15M | |
| Market Cap | $7.81B | $5.56B | $8.49B | $4.35B | $3.87B | $1.48B | $628M | $346M | $440M | $494M | $414M | $310M | |
| Enterprise Value | $7.98B | $5.57B | $8.44B | $4.34B | $3.80B | $1.44B | $636M | $346M | $346M | $457M | $364M | · | |
| P/E | -9.7 | -8.9 | -15.3 | -10.6 | -16.3 | -10.5 | · | · | -3.1 | 31.2 | -10.8 | -19.5 | |
| P/S | 88.7 | 301.0 | 1126.9 | 45.9 | 54.9 | 26.4 | 23.4 | 11.0 | 32.9 | 4.6 | 14.4 | 6.6 | |
| P/B | -11.8 | -41.1 | -22.0 | -40.3 | 15.8 | 13.0 | -57.4 | 13.3 | 4.0 | 5.2 | 6.0 | 3.4 | |
| P / Tangible Book | · | · | · | · | 15.8 | 13.0 | · | · | · | · | · | · | |
| P / Cash Flow | -15.3 | -14.0 | -20.5 | -14.5 | -27.1 | 165.0 | -6.9 | -3.4 | -4.3 | 13.4 | 84.8 | -6.9 | |
| P / FCF | -14.6 | -13.9 | -20.4 | -14.0 | -20.2 | -699.7 | -6.7 | -3.4 | -4.2 | 14.0 | 95.8 | -6.7 | |
| EV / EBITDA | -13.2 | -10.6 | -17.4 | -13.6 | -20.6 | -15.6 | -6.5 | -3.9 | -3.1 | 23.5 | -9.9 | · | |
| EV / FCF | -14.9 | -13.9 | -20.3 | -14.0 | -19.9 | -682.3 | -6.8 | -3.4 | -3.3 | 12.9 | 84.1 | · | |
| EV / Revenue | 90.6 | 301.5 | 1121.0 | 45.9 | 54.0 | 25.8 | 23.7 | 11.0 | 25.9 | 4.3 | 12.7 | · | |
| Earnings Yield | -10.3% | -11.2% | -6.5% | -9.4% | -6.1% | -9.5% | · | · | -31.8% | 3.2% | -9.3% | -5.1% |
Laporan Laba Rugi 14
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $19M | $18M | $2M | $67M | $2M | $17M | $463.0K | $249.0K | $835.0K | $2M | $378.0K | $867.0K | $5M | $2M | $3M | |
| R&D Expense | $98M | $96M | $104M | $99M | $110M | $98M | $94M | $85M | $80M | $82M | $85M | $83M | $83M | $79M | $75M | $63M | |
| SG&A Expense | $104M | $105M | $92M | $69M | $66M | $57M | $62M | $57M | $51M | $46M | $44M | $40M | $40M | $50M | $54M | $48M | |
| Operating Expenses | $208M | $203M | $196M | $169M | $178M | $157M | $156M | $141M | $130M | $127M | $129M | $123M | $123M | $129M | $129M | $111M | |
| Operating Income | $-179M | $-184M | $-178M | $-167M | $-112M | $-156M | $-139M | $-141M | $-130M | $-126M | $-127M | $-122M | $-122M | $-124M | $-127M | $-108M | |
| Interest Expense | · | · | $14M | $11M | $11M | · | $9M | $9M | $13M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | |
| Other Non-op | $14M | $11M | $11M | $10M | $13M | $14M | $15M | $17M | $12M | $8M | $8M | $7M | $7M | $6M | $6M | $4M | |
| Net Income | $-199M | $-206M | $-183M | $-306M | $-134M | $-161M | $-150M | $-161M | $-143M | $-136M | $-137M | $-129M | $-129M | $-131M | $-137M | $-142M | |
| EPS (Basic) | $-1.50 | $-1.67 | $-1.51 | $-2.55 | $-1.12 | $-1.36 | $-1.26 | $-1.36 | $-1.31 | $-1.33 | $-1.38 | $-1.35 | $-1.34 | $-1.38 | $-1.53 | $-1.52 | |
| EPS (Diluted) | $-1.50 | $-1.67 | $-1.51 | $-2.55 | $-1.12 | $-1.36 | $-1.26 | $-1.36 | $-1.31 | $-1.33 | $-1.38 | $-1.35 | $-1.34 | $-1.38 | $-1.53 | $-1.52 | |
| Shares (Basic) | 132,086 | 123,273 | -237,832 | 119,982 | 119,457 | 118,496 | -216,870 | 117,685 | 109,240 | 101,924 | -190,466 | 96,071 | 95,755 | 95,164 | -174,660 | 93,758 | |
| Shares (Diluted) | 132,086 | 123,273 | -237,832 | 119,982 | 119,457 | 118,496 | -216,870 | 117,685 | 109,240 | 101,924 | -190,466 | 96,071 | 95,755 | 95,164 | -174,660 | 93,758 | |
| EBITDA | $-179M | $-180M | · | $-167M | $-112M | $-153M | · | $-141M | $-130M | $-124M | · | $-122M | $-122M | $-123M | · | $-108M |
Neraca 24
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $255M | $130M | $123M | $225M | $75M | $74M | $95M | $47M | $190M | $120M | · | $100M | $69M | $102M | · | $106M | |
| Receivables | $24M | $7M | $18M | $2M | $8M | $2M | $17M | $244.0K | $0 | $834.0K | · | $2M | $985.0K | $1M | · | $2M | |
| Inventory | $380.0K | $154.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $18M | $14M | $17M | $13M | $20M | $16M | $15M | $7M | $11M | $19M | · | $20M | $20M | $16M | · | $14M | |
| Current Assets | $1.21B | $839M | $917M | $977M | $887M | $956M | $1.11B | $1.02B | $1.07B | $639M | · | $561M | $587M | $681M | · | $884M | |
| PP&E (Net) | $79M | $82M | $79M | $76M | $70M | $67M | $66M | $64M | $66M | $68M | · | $76M | $77M | $79M | · | $80M | |
| PP&E (Gross) | · | · | $126M | · | · | · | $103M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $47M | · | · | · | $37M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $19M | $18M | $17M | $17M | $15M | $13M | $8M | $8M | $8M | $8M | · | $8M | $8M | $8M | · | · | |
| Total Assets | $1.92B | $1.27B | $1.42B | $1.44B | $1.23B | $1.26B | $1.40B | $1.44B | $1.52B | $808M | · | $741M | $780M | $890M | · | $1.08B | |
| Accounts Payable | $21M | $25M | $22M | $22M | $16M | $14M | $20M | $12M | $9M | $13M | · | $14M | $13M | $17M | · | $14M | |
| Accrued Liabilities | $77M | $69M | $83M | $62M | $52M | $43M | $55M | $50M | $40M | $40M | · | $33M | $31M | $36M | · | $40M | |
| Current Liabilities | $181M | $199M | $202M | $142M | $131M | $160M | $180M | $110M | $103M | $89M | · | $78M | $66M | $75M | · | $76M | |
| Capital Leases | $102M | $105M | $108M | $111M | $111M | $113M | $113M | $115M | $117M | $119M | · | $122M | $124M | $125M | · | $114M | |
| Other Non-current Liabilities | · | · | · | $2M | $2M | $3M | · | $0 | $0 | $2.0K | · | $408.0K | $625.0K | $837.0K | · | $1M | |
| Total Liabilities | $2.10B | $2.10B | $2.08B | $1.96B | $1.59B | $1.53B | $1.54B | $1.45B | $1.42B | $1.20B | · | $1.18B | $1.11B | $1.12B | · | $1.09B | |
| Long-term Debt | $276M | $292M | $288M | $1.00B | $610M | $610M | $105M | $620M | $629M | $630M | · | · | · | · | · | · | |
| Total Debt | $276M | $292M | · | $176M | $173M | $105M | · | $105M | $104M | $68M | · | $61M | $62M | $64M | · | $64M | |
| Common Stock | $138.0K | $124.0K | $123.0K | $122.0K | $119.0K | $119.0K | $118.0K | $118.0K | $117.0K | $105.0K | · | $94.0K | $94.0K | $94.0K | · | $93.0K | |
| Retained Earnings | $-3.89B | $-3.69B | $-3.49B | $-3.30B | $-3.00B | $-2.86B | $-2.70B | $-2.55B | $-2.39B | $-2.25B | · | $-1.98B | $-1.85B | $-1.72B | · | $-1.45B | |
| AOCI | $-4M | $-2M | $630.0K | $34.0K | $-158.0K | $2M | $2M | $5M | $-1M | $-539.0K | · | $-874.0K | $-1M | $-2M | · | $-6M | |
| Stockholders' Equity | $-173M | $-827M | $-660M | $-521M | $-369M | $-266M | $-135M | $-14M | $109M | $-396M | $-386M | $-439M | $-333M | $-229M | $-108M | $-16M | |
| Liabilities + Equity | $1.92B | $1.27B | $1.42B | $1.44B | $1.23B | $1.26B | $1.40B | $1.44B | $1.52B | $808M | · | $741M | $780M | $890M | · | $1.08B | |
| Shares Outstanding | · | · | 122,943,172 | · | · | · | 118,209,139 | · | · | · | · | · | · | · | · | · |
Arus Kas 12
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $6M | $2M | $2M | $2M | $2M | $1M | |
| Stock-based Comp | $36M | $30M | $31M | $31M | $28M | $24M | $26M | $25M | $25M | $22M | $19M | $19M | $19M | $15M | $13M | $13M | |
| Other Non-cash | · | $27M | · | · | · | $4M | · | · | · | $-18M | · | · | · | $-8M | · | · | |
| Operating Cash Flow | $-160M | $-145M | $-143M | $-108M | $-128M | $-132M | $-66M | $-102M | $-99M | $-130M | $-74M | $-96M | $-122M | $-122M | $-98M | $-84M | |
| CapEx | $4M | $6M | $6M | $9M | $4M | $6M | $1M | $701.0K | $2M | $0 | $77.0K | $220.0K | $717.0K | $402.0K | $3M | $6M | |
| Investing Cash Flow | $-507M | $145M | $-71M | $-71M | $53M | $106M | $111M | $-45M | $-652M | $33M | $-81M | $73M | $82M | $165M | $29M | $-292M | |
| Net Debt Issued | · | $-3M | · | · | · | $-3M | · | · | · | $-705.0K | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | $0 | $0 | · | · | · | $94M | · | · | · | $0 | · | · | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $94M | · | · | · | · | · | · | |
| Financing Cash Flow | $793M | $8M | $111M | $330M | $79M | $5M | $2M | $3M | $821M | $104M | $169M | $54M | $5M | $-7M | $30M | $389M | |
| Net Change in Cash | $125M | $7M | $-103M | $152M | $2M | $-21M | $48M | $-143M | $70M | $7M | $13M | $31M | $-34M | $36M | $-39M | $13M | |
| Free Cash Flow | · | $-151M | · | · | · | $-137M | · | · | · | $-130M | · | · | · | $-123M | · | · |
Profitabilitas 5
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -626.0% | -948.7% | · | -8613.4% | -167.0% | -9856.3% | · | -30410.6% | -52277.9% | -15118.0% | · | -32345.2% | -14077.2% | -2698.3% | · | -4311.8% | |
| Net Margin | -694.4% | -1064.5% | · | -15815.0% | -201.3% | -10220.1% | · | -34675.0% | -57557.4% | -16244.7% | · | -34238.6% | -14837.0% | -2846.1% | · | -5658.4% | |
| EBITDA Margin | -626.0% | -931.2% | · | -8613.4% | -167.0% | -9710.6% | · | -30410.6% | -52277.9% | -14838.8% | · | -32345.2% | -14077.2% | -2658.2% | · | -4311.8% | |
| ROA | -12.6% | -16.2% | · | -21.3% | -9.8% | -15.6% | · | -14.8% | -12.4% | -16.0% | · | -14.2% | -16.6% | -15.0% | · | -14.9% | |
| ROE | 73.3% | 37.7% | · | 114.5% | 103.3% | 48.7% | · | 70.9% | 127.6% | 43.4% | · | 56.9% | 116.1% | 232.9% | · | -122.1% |
Likuiditas & Solvabilitas 5
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.7 | 4.2 | · | 6.9 | 6.8 | 6.0 | · | 9.3 | 10.4 | 7.2 | · | 7.2 | 8.9 | 9.0 | · | 11.6 | |
| Quick Ratio | 1.5 | 0.7 | · | 1.6 | 0.6 | 0.5 | · | 0.4 | 1.9 | 1.4 | · | 1.3 | 1.1 | 1.4 | · | 1.4 | |
| Debt / Equity | -1.6 | -0.4 | · | -0.3 | -0.5 | -0.4 | · | -7.5 | 1.0 | -0.2 | · | -0.1 | -0.2 | -0.3 | · | -4.0 | |
| LT Debt / Equity | -1.4 | -0.3 | · | -0.3 | -0.4 | -0.3 | · | -6.7 | 0.9 | -0.1 | · | -0.1 | -0.2 | -0.3 | · | -4.0 | |
| Interest Coverage | · | · | · | -14.7 | -10.1 | · | · | -15.8 | -10.2 | -17.8 | · | -17.1 | -17.3 | -17.9 | · | -15.9 |
Efisiensi 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 1.7 | 4.4 | · | 1.9 | 15.9 | 1.1 | · | 0.3 | 0.5 | 0.9 | · | 0.2 | 0.6 | 1.3 | · | 1.7 |
Valuasi (TTM) 4
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $117M | $90M | · | $71M | $69M | $3M | · | $2M | $2M | $7M | · | $8M | $97M | $97M | · | $98M | |
| Net Income TTM | $-845M | $-808M | · | $-762M | $-600M | $-601M | · | $-569M | $-537M | $-525M | · | $-532M | $-422M | $-383M | · | $-328M | |
| P/E | -12.5 | -9.8 | · | -8.6 | -6.4 | -7.5 | · | -9.9 | -10.2 | -13.0 | · | -5.3 | -7.3 | -8.4 | · | -12.9 | |
| Earnings Yield | -8.0% | -10.2% | · | -11.6% | -15.6% | -13.3% | · | -10.1% | -9.8% | -7.7% | · | -19.0% | -13.7% | -11.9% | · | -7.7% |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Pendapatan | $88M | $18M | $8M | $95M | $70M |
| Margin Operasi % | -695.4% | -2902.7% | -6589.7% | -342.8% | -264.5% |
| Laba Bersih | $-785M | $-590M | $-526M | $-389M | $-215M |
| EPS Dilusian | $-6.54 | $-5.26 | $-5.45 | $-4.33 | $-2.80 |
Neraca
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Utang / Ekuitas | -0.4 | -0.8 | -0.2 | -0.6 | 0.2 |
| Rasio Lancar | 4.5 | 6.2 | 6.1 | 9.4 | 7.5 |
| Rasio Cepat | 0.7 | 0.6 | 1.1 | 0.8 | 2.3 |
Arus Kas
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-535M | $-400M | $-416M | $-311M | $-191M |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 539 pengaju · $9.0B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 104 (+7 vs Kuartal sebelumnya) | 49 (-8 vs Kuartal sebelumnya) | 222 (+45 vs Kuartal sebelumnya) | 112 (-32 vs Kuartal sebelumnya) | +17.8M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| VANGUARD PORTFOLIO MANAGEMENT LLC | $571.778.157 | 6.711.799 | 6,37% | Saham |
| STATE STREET CORP | $553.243.709 | 6.494.233 | 6,16% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $521.151.103 | 6.117.515 | 5,80% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $509.521.049 | 5.980.996 | 5,68% | Saham |
| Avoro Capital Advisors LLC | $425.949.915 | 4.999.999 | 4,74% | Saham |
| FMR LLC | $375.035.430 | 4.402.341 | 4,18% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $259.207.450 | 3.042.018 | 2,89% | Saham |
| BANK OF AMERICA CORP /DE/ | $251.706.463 | 2.954.648 | 2,80% | Saham |
| RTW INVESTMENTS, LP | $243.814.036 | 2.862.003 | 2,72% | Saham |
| Polar Capital Holdings Plc | $191.988.358 | 2.253.649 | 2,14% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $161.060.214 | 1.890.600 | 1,79% | Opsi beli |
| Capital Research Global Investors | $143.683.584 | 1.686.625 | 1,60% | Saham |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $136.597.224 | 1.603.442 | 1,52% | Saham |
| Integral Health Asset Management, LLC | $136.304.000 | 1.600.000 | 1,52% | Saham |
| Point72 Asset Management, L.P. | $135.257.185 | 1.587.712 | 1,51% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $133.386.924 | 1.565.758 | 1,49% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $131.998.327 | 1.549.458 | 1,47% | Saham |
| PRINCIPAL FINANCIAL GROUP INC | $111.435.932 | 1.308.087 | 1,24% | Saham |
| Capital International Investors | $111.245.191 | 1.305.848 | 1,24% | Saham |
| ARMISTICE CAPITAL, LLC | $106.487.500 | 1.250.000 | 1,19% | Opsi beli |
| ARMISTICE CAPITAL, LLC | $102.342.325 | 1.201.342 | 1,14% | Saham |
| Pictet Asset Management Holding SA | $99.038.455 | 1.160.463 | 1,10% | Saham |
| Frazier Life Sciences Management, L.P. | $98.810.092 | 1.159.879 | 1,10% | Saham |
| Holocene Advisors, LP | $97.506.685 | 1.144.579 | 1,09% | Saham |
| Woodline Partners LP | $93.769.315 | 1.100.708 | 1,04% | Saham |
| NORGES BANK | $86.512.319 | 1.015.522 | 0,96% | Saham |
| Royalty Pharma Sub-Manager, LLC | $83.519.594 | 980.392 | 0,93% | Saham |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $81.937.000 | 961.815 | 0,91% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $77.218.175 | 906.423 | 0,86% | Saham |
| CITADEL ADVISORS LLC | $77.062.874 | 904.600 | 0,86% | Opsi beli |
| Melqart Asset Management (UK) Ltd | $65.385.455 | 767.525 | 0,73% | Saham |
| Siren, L.L.C. | $64.655.121 | 758.952 | 0,72% | Saham |
| Fisher Asset Management, LLC | $63.355.547 | 743.697 | 0,71% | Saham |
| Foresite Capital Management IV, LLC | $60.884.867 | 714.695 | 0,68% | Saham |
| Balyasny Asset Management L.P. | $60.599.821 | 711.349 | 0,67% | Saham |
| Deep Track Capital, LP | $59.633.000 | 700.000 | 0,66% | Saham |
| JANE STREET GROUP, LLC | $59.633.000 | 700.000 | 0,66% | Opsi beli |
| BNP PARIBAS FINANCIAL MARKETS | $58.702.470 | 689.077 | 0,65% | Saham |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | $56.251.809 | 660.310 | 0,63% | Saham |
| CITADEL ADVISORS LLC | $54.601.338 | 640.936 | 0,61% | Saham |
| GOLDMAN SACHS GROUP INC | $54.053.311 | 634.503 | 0,60% | Saham |
| Qube Research & Technologies Ltd | $48.774.257 | 572.535 | 0,54% | Saham |
| EVENTIDE ASSET MANAGEMENT, LLC | $48.081.832 | 564.398 | 0,54% | Saham |
| Affinity Asset Advisors, LLC | $46.854.500 | 550.000 | 0,52% | Saham |
| First Turn Management, LLC | $44.930.228 | 527.412 | 0,50% | Saham |
| AMERICAN CENTURY COMPANIES INC | $44.162.525 | 518.398 | 0,49% | Saham |
| Caption Management, LLC | $43.651.356 | 512.400 | 0,49% | Opsi beli |
| D. E. Shaw & Co., Inc. | $40.874.247 | 479.801 | 0,46% | Saham |
| Checkpoint Capital L.P. | $40.465.250 | 475.000 | 0,45% | Saham |
| Hood River Capital Management LLC | $39.977.367 | 469.273 | 0,45% | Saham |
| RP Management, LLC | $39.401.954 | 980.392 | 0,44% | Saham |
| EMERALD ADVISERS, LLC | $39.013.272 | 457.956 | 0,43% | Saham |
| ADAR1 Capital Management, LLC | $39.009.097 | 457.907 | 0,43% | Saham |
| AMERIPRISE FINANCIAL INC | $38.010.006 | 446.179 | 0,42% | Saham |
| Candriam S.C.A. | $37.708.477 | 443.066 | 0,42% | Saham |
| MARSHALL WACE, LLP | $36.259.335 | 425.629 | 0,40% | Saham |
| RHUMBLINE ADVISERS | $35.933.015 | 421.799 | 0,40% | Saham |
| CITADEL ADVISORS LLC | $35.882.028 | 421.200 | 0,40% | Opsi jual |
| ALLIANCEBERNSTEIN L.P. | $35.327.299 | 535.993 | 0,39% | Saham |
| GILDER GAGNON HOWE & CO LLC | $34.096.829 | 400.245 | 0,38% | Saham |
| TD Asset Management Inc | $32.809.225 | 385.130 | 0,37% | Saham |
| BlackRock, Inc. | $29.124.928 | 341.882 | 0,32% | Saham |
| GSK plc | $29.001.573 | 340.434 | 0,32% | Saham |
| TWO SIGMA INVESTMENTS, LP | $27.040.243 | 317.411 | 0,30% | Saham |
| CITIGROUP INC | $26.852.314 | 315.205 | 0,30% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $24.671.024 | 289.600 | 0,27% | Opsi jual |
| Trails Edge Capital Partners, LP | $24.542.302 | 288.089 | 0,27% | Saham |
| EMERALD MUTUAL FUND ADVISERS TRUST | $23.833.521 | 279.769 | 0,27% | Saham |
| Polaris Capital Management, LLC | $22.737.211 | 266.900 | 0,25% | Saham |
| SEGALL BRYANT & HAMILL, LLC | $21.899.197 | 257.063 | 0,24% | Saham |
| Alyeska Investment Group, L.P. | $21.297.500 | 250.000 | 0,24% | Saham |
| ExodusPoint Capital Management, LP | $21.234.374 | 249.259 | 0,24% | Saham |
| Capital World Investors | $21.196.550 | 248.815 | 0,24% | Saham |
| Walleye Capital LLC | $20.422.428 | 239.728 | 0,23% | Saham |
| E. Ohman J:or Asset Management AB | $19.823.223 | 300.762 | 0,22% | Saham |
| Sarissa Capital Management LP | $19.476.393 | 228.623 | 0,22% | Saham |
| Swiss National Bank | $18.946.256 | 222.400 | 0,21% | Saham |
| SPHERA FUNDS MANAGEMENT LTD. | $18.740.693 | 219.987 | 0,21% | Saham |
| BAKER BROS. ADVISORS LP | $17.997.836 | 211.267 | 0,20% | Saham |
| California Public Employees Retirement System | $17.979.520 | 211.052 | 0,20% | Saham |
| Nicholas Investment Partners, LP | $17.810.758 | 209.071 | 0,20% | Saham |
| PINNACLE ASSOCIATES LTD | $17.245.864 | 202.440 | 0,19% | Saham |
| Mirador Capital Partners LP | $17.239.900 | 202.370 | 0,19% | Saham |
| Tri Locum Partners LP | $16.526.860 | 194.000 | 0,18% | Saham |
| PFM Health Sciences, LP | $16.329.730 | 191.686 | 0,18% | Saham |
| Rock Springs Capital Management LP | $16.014.016 | 187.980 | 0,18% | Saham |
| PRUDENTIAL FINANCIAL INC | $15.933.512 | 187.035 | 0,18% | Saham |
| DAFNA Capital Management LLC | $14.652.510 | 171.998 | 0,16% | Saham |
| Ghisallo Capital Management LLC | $14.482.300 | 170.000 | 0,16% | Saham |
| Impax Asset Management Group plc | $14.056.350 | 165.000 | 0,16% | Saham |
| Lombard Odier Asset Management (Europe) Ltd | $13.494.096 | 158.400 | 0,15% | Opsi beli |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $13.383.349 | 157.100 | 0,15% | Saham |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $13.330.276 | 156.477 | 0,15% | Saham |
| JANE STREET GROUP, LLC | $12.735.905 | 149.500 | 0,14% | Opsi jual |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $12.145.719 | 139.190 | 0,14% | Saham |
| Retirement Systems of Alabama | $11.962.891 | 140.426 | 0,13% | Saham |
| MetLife Investment Management, LLC | $11.930.519 | 140.046 | 0,13% | Saham |
| Polymer Capital Management (HK) LTD | $11.777.943 | 138.255 | 0,13% | Saham |
| Cinctive Capital Management LP | $11.742.419 | 137.838 | 0,13% | Saham |
| TUDOR INVESTMENT CORP ET AL | $11.279.156 | 132.400 | 0,13% | Opsi beli |
Orang dalam perusahaan 52 orang dalam · 18 pejabat · 22 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Sung Lee | EVP, Chief Financial Officer | 1 Juli 2026 M | 63.221 | 0 | 5 | $-5.695.855 |
| Ching Jaw | SVP Finance & CFO | 6 Maret 2023 A | 87.346 | 0 | 0 | $0 |
| Sharon Surrey Barbari | EVP, Finance & CFO | 28 Feb. 2017 F | 40.323 | 0 | 0 | $0 |
| Fady Ibraham Malik | EVP Research & Development | 18 Agu 2026 M | 153.902 | 0 | 22 | $-4.429.370 |
| Andrew Callos | EVP, Chief Commercial Officer | 30 Juli 2026 M | 58.555 | 0 | 24 | $-15.318.893 |
| Jeffrey Hessekiel | Chief Legal & Admin Officer | 15 Maret 2026 A | 107.943 | 0 | 0 | $0 |
| Robert Wong | VP, Chief Accounting Officer | 3 Des. 2024 A | 18.655 | 0 | 0 | $0 |
| Brett A Pletcher | EVP, Chief Legal Officer | 30 Agu 2024 A | 33.140 | 0 | 0 | $0 |
| Mark A Schlossberg | SVP - Legal & General Counsel | 15 Maret 2022 M | 103.408 | 0 | 0 | $0 |
| David Cragg | Chief HR & Admin Officer | 7 Maret 2022 F | 153.233 | 0 | 0 | $0 |
| Caryn Gordon Mcdowell | GC & Chief Compliance Officer | 27 Feb. 2018 A | 32.548 | 0 | 0 | $0 |
| Peter S Roddy | SVP Finance & CAO | 27 Feb. 2018 A | 21.520 | 0 | 0 | $0 |
| Bradley Paul Morgan | SVP Drug Discovery & Early Dev | 31 Agu 2017 M | 46.441 | 0 | 0 | $0 |
| Bonnie Charpentier | SVP Regulatory & Compliance | 28 Feb. 2017 A | 29.004 | 0 | 0 | $0 |
| Andrew A Wolff | SVP & CMO | 28 Feb. 2017 A | 47.255 | 0 | 0 | $0 |
| David J Morgans JR | EVP-Preclinical R&D | 28 Feb. 2011 A | 42.000 | 0 | 0 | $0 |
| Michael Rabson | SVP Business Dev/Legal & GC | 18 Des. 2009 M | 20.043 | 0 | 0 | $0 |
| Jay K Trautman | VP, Discovery Research | 29 Feb. 2008 A | 47.896 | 0 | 0 | $0 |
| Robert Arthur Harrington | Direktur | 15 Juli 2026 A | 21.932 | 0 | 2 | $-248.260 |
| James M Daly | Direktur | 15 Juli 2026 A | 3.390 | 0 | 0 | $0 |
| Edward M. Kaye MD | Direktur | 15 Juli 2026 A | 10.434 | 0 | 6 | $-3.544.372 |
| Nancy Wysenski | Direktur | 15 Juli 2026 A | 33.992 | 0 | 0 | $0 |
| Wendell Wierenga | Direktur | 15 Juli 2026 A | 35.563 | 0 | 3 | $-1.881.925 |
| John T Henderson | Direktur | 15 Juli 2026 A | 78.360 | 0 | 2 | $-2.078.525 |
| Lynne B Parshall | Direktur | 1 Juni 2026 S | 15.784 | 0 | 3 | $-1.000.100 |
| Muna Bhanji | Direktur | 27 Mei 2026 A | 26.361 | 0 | 0 | $0 |
| Robert E Landry | Direktur | 27 Mei 2026 A | 10.184 | 0 | 0 | $0 |
| Wendall Wierenga | Direktur | 15 Juli 2025 A | 32.345 | 0 | 0 | $0 |
| COSTA SANTO J | Direktur | 15 Mei 2024 A | 20.600 | 0 | 0 | $0 |
| Sandford D Smith | Direktur | 2 Jan. 2024 A | 18.801 | 0 | 0 | $0 |
| Robert Califf | Direktur | 3 Jan. 2022 A | 6.003 | 0 | 0 | $0 |
| GAGE L PATRICK | Direktur | 8 Nov. 2021 M | 28.932 | 0 | 0 | $0 |
| Denise Gilbert | Direktur | 20 Mei 2015 J | — | 0 | 0 | $0 |
| Stephen M Dow | Direktur | 2 Jan. 2013 A | 1.421.052 | 0 | 0 | $0 |
| James A Spudich | Direktur | 18 Mei 2011 A | 180.600 | 0 | 0 | $0 |
| Grant A Heidrich III | Direktur | 3 Jan. 2011 A | 93.755 | 0 | 0 | $0 |
| Michael Schmertzler | Direktur | 3 Juni 2010 S | 4.340.923 | 0 | 0 | $0 |
| Mark Mcdade | Direktur | 21 Mei 2009 A | — | 0 | 0 | $0 |
| Charles J Homcy | Direktur | 22 Mei 2008 A | — | 0 | 0 | $0 |
| William J Rutter | Direktur | 29 April 2004 C | 172.413 | 0 | 0 | $0 |
| SEVIN ROSEN FUND VI LP | Pemilik 10% | 29 April 2004 C | 1.615.716 | 0 | 0 | $0 |
| SRB ASSOCIATES VIII LP | Pemilik 10% | 29 April 2004 C | 771.052 | 0 | 0 | $0 |
| SRB ASSOCIATES VII LP | Pemilik 10% | 29 April 2004 C | 650.000 | 0 | 0 | $0 |
| SEVIN ROSEN FUND VIII LP | Pemilik 10% | 29 April 2004 C | 755.631 | 0 | 0 | $0 |
| Robert I Blum | — | 10 Agu 2026 M | 377.820 | 0 | 19 | $-9.702.097 |
| Elisabeth Schnieders | — | 28 Feb. 2017 A | 43.919 | 0 | 0 | $0 |
| James H Sabry | — | 3 Juni 2010 M | 0 | 0 | 0 | $0 |
| SEVIN ROSEN VII AFFILIATES FUND LP | — | 29 April 2004 C | 24.050 | 0 | 0 | $0 |
| SEVIN ROSEN FUND VII LP | — | 29 April 2004 C | 625.950 | 0 | 0 | $0 |
| SRB ASSOCIATES VI LP | — | 29 April 2004 C | 1.742.951 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 84 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| LFSC · RBB Fund, Inc. | 3,16% | 43.268 NS | 31 Mei 2026 | N-PORT |
| HRTS · Tema ETF Trust | 2,52% | 17.069 NS | 31 Mei 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1,81% | 58.136 SH | 8 Agu 2026 | Harian |
| FMED · Fidelity Covington Trust | 1,55% | 8.262 NS | 31 Mei 2026 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 1,40% | 3.663 NS | 31 Mei 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 1,24% | 189.801 NS | 30 April 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 0,98% | 48.338 NS | 30 April 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,94% | 76.297 NS | 30 April 2026 | N-PORT |
| IBB · iShares Trust | 0,75% | 874.995 SH | 8 Agu 2026 | Harian |
| BBC · ETFis Series Trust I | 0,75% | 4.355 NS | 30 April 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,71% | 7.377 SH | 8 Agu 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,64% | 102.933 SH | 8 Agu 2026 | Harian |
| IWN · iShares Trust | 0,62% | 1.099.434 SH | 8 Agu 2026 | Harian |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,51% | 41.612 NS | 30 April 2026 | N-PORT |
| BIB · ProShares Trust | 0,47% | 4.553 NS | 31 Mei 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,47% | 94.565 NS | 30 April 2026 | N-PORT |
| MIDE · DBX ETF Trust | 0,41% | 178 NS | 29 Mei 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,37% | 21.543 SH | 8 Agu 2026 | Harian |
| XJH · iShares Trust | 0,35% | 18.349 SH | 8 Agu 2026 | Harian |
| IQSM · New York Life Investments ETF Trust | 0,34% | 16.959 NS | 30 April 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,34% | 761.130 SH | 8 Agu 2026 | Harian |
| IWM · iShares Trust | 0,34% | 3.349.200 SH | 8 Agu 2026 | Harian |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,33% | 72.343 SH | 8 Agu 2026 | Harian |
| VBK · VANGUARD INDEX FUNDS | 0,32% | 1.797.986 SH | 8 Agu 2026 | Harian |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,32% | 219.413 SH | 8 Agu 2026 | Harian |
| IJK · iShares Trust | 0,32% | 429.311 SH | 8 Agu 2026 | Harian |
| ISCG · iShares Trust | 0,32% | 38.968 SH | 8 Agu 2026 | Harian |
| IVOV · VANGUARD ADMIRAL FUNDS | 0,31% | 53.623 SH | 8 Agu 2026 | Harian |
| IJH · iShares Trust | 0,30% | 4.684.495 SH | 8 Agu 2026 | Harian |
| IJJ · iShares Trust | 0,29% | 317.724 SH | 8 Agu 2026 | Harian |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,26% | 55.086 NS | 30 April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,25% | 6.062 NS | 31 Mei 2026 | N-PORT |
| RSSL · Global X Funds | 0,23% | 51.834 NS | 30 April 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,23% | 14.028 NS | 30 April 2026 | N-PORT |
| MVV · ProShares Trust | 0,22% | 4.565 NS | 31 Mei 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,21% | 635.330 NS | 31 Mei 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0,20% | 19.862 NS | 30 April 2026 | N-PORT |
| ESML · iShares Trust | 0,20% | 72.711 SH | 8 Agu 2026 | Harian |
| SCHM · SCHWAB STRATEGIC TRUST | 0,19% | 356.940 NS | 31 Mei 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0,19% | 37.821 NS | 30 April 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,17% | 40.586 SH | 8 Agu 2026 | Harian |
| ISCB · iShares Trust | 0,16% | 5.525 SH | 8 Agu 2026 | Harian |
| MIDU · Direxion Shares ETF Trust | 0,15% | 2.025 NS | 30 April 2026 | N-PORT |
| UMDD · ProShares Trust | 0,15% | 638 NS | 31 Mei 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,15% | 11.444 NS | 30 April 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 47.609 NS | 30 April 2026 | N-PORT |
| UWM · ProShares Trust | 0,15% | 4.765 NS | 31 Mei 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,15% | 2.868 NS | 30 April 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,14% | 3.113.794 SH | 8 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,14% | 333.056 SH | 8 Agu 2026 | Harian |